ABL Bio Inc. (KOSDAQ:298380)
South Korea · Delayed Price · Currency is KRW 190,500
+500 (0.26%)
Mar 20, 2026, 3:30 PM KST
369.79% (1Y)
| Market Cap | 10.67T +465.0% |
| Revenue (ttm) | 79.35B +137.6% |
| Net Income | -37.81B |
| EPS | -734.00 |
| Shares Out | 55.99M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 767,572 |
| Average Volume | 644,596 |
| Open | 191,900 |
| Previous Close | 190,000 |
| Day's Range | 188,900 - 194,800 |
| 52-Week Range | 31,300 - 257,500 |
| Beta | 0.47 |
| RSI | 50.93 |
| Earnings Date | Mar 26, 2026 |